{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T17:22:16Z","timestamp":1767374536136},"reference-count":54,"publisher":"Informa Healthcare","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[1998,10]]},"DOI":"10.1517\/13543784.7.10.1701","type":"journal-article","created":{"date-parts":[[2005,5,4]],"date-time":"2005-05-04T16:58:18Z","timestamp":1115225898000},"page":"1701-1717","source":"Crossref","is-referenced-by-count":4,"title":["Abciximab (Reopro): a clinically effective glycoprotein IIb\/IIIa receptor blocker"],"prefix":"10.1517","volume":"7","author":[{"given":"MA","family":"de Belder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AGC","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","published-online":{"date-parts":[[2005,2,23]]},"reference":[{"key":"CIT0001","first-page":"391","volume":"85","author":"STARY HC","year":"1992","journal-title":"A report from the com-mittee on vascular lesions of the council on athero-sclerosis. Am. Heart Assoc. Circulation"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(94)90657-2"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309023291001"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199303113281002"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199303113281001"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(94)90675-0"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(87)90233-9"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198610163151602"},{"key":"CIT0013","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1182\/blood.V73.4.961.961","volume":"72","author":"BADIMON L","year":"1989","journal-title":"Blood"},{"key":"CIT0014","first-page":"1549","volume":"322","author":"TRIP MD","year":"1990","journal-title":"Platelet hy-perreactivity and prognosis in survivors of myocar-dial infarction. New Engl. J. Med."},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.6.9.1257"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199405053301808"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.308.6921.81"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.308.6922.159"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199604253341702"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)09457-3"},{"key":"CIT0022","first-page":"811","volume":"276","author":"OLER A","year":"1996","journal-title":"A meta-analysis. JAMA"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199311253292204"},{"key":"CIT0024","first-page":"1923","volume":"1995","author":"SIMES RJ","journal-title":"Circulation"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(92)90043-M"},{"key":"CIT0026","first-page":"920","volume":"79","author":"JANG I-K, GOLD HK, ZISKIND AA et al.","year":"1989","journal-title":"A possible explanation for resistance to coronary thrombolysis. Circulation"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199001043220107"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(87)90895-2"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)91270-2"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199708143370702"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(97)00094-6"},{"key":"CIT0033","first-page":"757","volume":"333","author":"SERRUYS PW","year":"1995","journal-title":"J. Med."},{"key":"CIT0034","first-page":"764","volume":"333","author":"BITTL JA","year":"1995","journal-title":"J. Med."},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199609123351103"},{"key":"CIT0040","first-page":"2083","volume":"94","author":"SCHULMAN SP","year":"1996","journal-title":"TOPOL EJet al.: Effects of integrilin, a platelet glycoprotein Ilb\/IIIa receptor antagonist in unstable angina. Circu-lation"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)10172-0"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.95.4.846"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199805213382103"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.96.5.1445"},{"key":"CIT0046","first-page":"899","volume":"94","author":"THEROUX P","year":"1996","journal-title":"Platelet membrane re- ceptor glycoprotein receptor Ilb\/IIIa antagonism in unstable angina. The Canadian Lamiflban Study. Circu-lation"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.92.9.2373"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114757"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1097\/00019501-199302000-00007"},{"key":"CIT0056","first-page":"1757","volume":"1994","author":"TCHENG JE","journal-title":"Circulation"},{"key":"CIT0057","first-page":"583","volume":"48","author":"FAULDS D","year":"1994","journal-title":"A review of its pharmacology and therapeutic potential in is-chaemic heart disease. Drugs"},{"key":"CIT0058","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(94)90586-X"},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.89.2.596"},{"key":"CIT0060","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199404073301402"},{"key":"CIT0061","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(96)00128-2"},{"key":"CIT0062","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(97)00110-1"},{"key":"CIT0063","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)90007-8"},{"key":"CIT0064","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03550060055036"},{"key":"CIT0067","first-page":"169","volume":"10","author":"SACRISTAN JA","year":"1996","journal-title":"Br. J. Med. Econ."},{"key":"CIT0068","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(96)00749-7"},{"key":"CIT0069","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199706123362401"},{"key":"CIT0070","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)10452-9"},{"key":"CIT0071","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.91.12.2882"},{"key":"CIT0072","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(94)90474-X"},{"key":"CIT0073","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.95.4.809"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/13543784.7.10.1701","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T06:32:43Z","timestamp":1586241163000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/13543784.7.10.1701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,10]]},"references-count":54,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2005,2,23]]},"published-print":{"date-parts":[[1998,10]]}},"alternative-id":["10.1517\/13543784.7.10.1701"],"URL":"https:\/\/doi.org\/10.1517\/13543784.7.10.1701","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,10]]}}}